Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Gynecologic Oncology|November 10, 2018
Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041)Jung-Yun Lee, Jeong-Yeol Park, Sang Yoon Park, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 28, 2019
Development of a Shape-Memory Tube to Prevent Vascular StenosisYong Cheol Shin, Jung Bok Lee, Dae-Hyun Kim, et al.
Oncotarget|January 20, 2018
Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinomaJi-Yong Yoon, Jeong-Ju Lee, Sujin Gu, et al.
Science Advances|April 29, 2021
Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctionsHyo-Jin Yoon, Yong Jae Lee, Sewoom Baek, et al.
Journal of Gynecologic Oncology|February 8, 2024
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancerSeung-Hyuk Shim, Jung-Yun Lee, Yoo-Young Lee, et al.
Aging Cell|November 26, 2019
Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid modelsHeesun Choi, Haeng Jun Kim, Jinhee Yang, et al.
The Lancet. Oncology|January 18, 2026
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trialNatalie Y L Ngoi, Jung-Yun Lee, Diana Lim, et al.
Cancers|November 3, 2020
Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)Min Chul Choi, Yong-Man Kim, Jeong-Won Lee, et al.
Lancet (London, England)|April 13, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trialDomenica Lorusso, Laurence Gladieff, David M O'Malley, et al.
Lancet (London, England)|June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trialAlexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
Pageof 38